Concepedia
Statistics
Publications
5
Citations
202
H-Index
Active since
1997
Affiliations
Orion Corporation (Finland)(Current)
Orion Corporation (United Kingdom)
Pasi Hakulinen is an author at Orion Corporation (Finland) specializing in oncology, breast cancer, and women's health.
Top concepts
MedicineOncologyMenopauseGynecologyPharmacologyBreast CancerEndocrinologyWomen's HealthPharmacotherapy
Publications per year
1997–2022
Estrogenic Effects of Toremifene and Tamoxifen in Postmenopausal Breast Cancer Patients
Juha Ellmén, Pasi Hakulinen, Anu Partanen et al. · Breast Cancer Research and Treatment · 2003 · 60 citations · Full text
Hormonal Contraceptive, Breast Oncology, Endocrine-related Cancer +11
Selegiline as the primary treatment of Parkinson's disease - a long-term double-blind study
Vilho V. Myllylä, K. A. Sotaniemi, Pasi Hakulinen et al. · Acta Neurologica Scandinavica · 1997 · 58 citations
A double-blind, randomized, placebo-controlled crossover trial of the 2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis
Ariane L. Herrick, Andrea Murray, A. Rück et al. · Lara D. Veeken · 2014 · 34 citations · Full text
Tolerability of ORM‐12741 and effects on episodic memory in patients with Alzheimer's disease
Juha O. Rinne, Keith Wesnes, Jeffrey L. Cummings et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2016 · 29 citations · Full text
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis
Mari Karimaa, Reetta Riikonen, Henna Kettunen et al. · Molecular Cancer Therapeutics · 2022 · 21 citations · Full text
1–5 of 5